152 related articles for article (PubMed ID: 2461130)
21. Cystometry in dogs under oxymorphone and acepromazine restraint.
Barsanti JA; Mahaffey MB; Crowell WA; Barber DL
Am J Vet Res; 1984 Oct; 45(10):2152-3. PubMed ID: 6208826
[TBL] [Abstract][Full Text] [Related]
22. Ability of flumazenil, butorphanol, and naloxone to reverse the anesthetic effects of oxymorphone-diazepam in dogs.
Lemke KA; Tranquilli WJ; Thurmon JC; Benson GJ; Olson WA
J Am Vet Med Assoc; 1996 Aug; 209(4):776-9. PubMed ID: 8756878
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
[TBL] [Abstract][Full Text] [Related]
24. [Analgesic activity of various morphine derivatives on the Afghan pika (Ochotona rufescens rufescens): tolerance of the acute effects of morphine].
Puget A
Zentralbl Veterinarmed A; 1980 Apr; 27(2):157-64. PubMed ID: 6157270
[No Abstract] [Full Text] [Related]
25. Cardiovascular effects of epidurally administered morphine and a xylazine-morphine combination in isoflurane-anesthetized dogs.
Keegan RD; Greene SA; Weil AB
Am J Vet Res; 1995 Apr; 56(4):496-500. PubMed ID: 7785829
[TBL] [Abstract][Full Text] [Related]
26. The release of morphine from the mast cells by 48/80 in morphine perfused dogs.
Akcasu A; Eyüboğlu H; Köseoğlu A
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):33-7. PubMed ID: 2580806
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of preventing hypotension with H1/H2 antagonists before protamine administration].
Behne M; Bremerich D; Schiesser S; Asskali F
Infusionsther Transfusionsmed; 1994 Apr; 21(2):81-5. PubMed ID: 7517238
[TBL] [Abstract][Full Text] [Related]
28. Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog.
Schurig JE; Cavanagh RL; Buyniski JP
Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):296-304. PubMed ID: 686916
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study.
Bateman SW; Haldane S; Stephens JA
Vet Anaesth Analg; 2008 Jul; 35(4):341-7. PubMed ID: 18363580
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of intravenous bolus administration and infusion of ketamine-midazolam in isoflurane-anesthetized dogs.
Jacobson JD; Hartsfield SM
Am J Vet Res; 1993 Oct; 54(10):1715-20. PubMed ID: 8250398
[TBL] [Abstract][Full Text] [Related]
31. Cardiopulmonary effects of anesthetic induction with thiopental, propofol, or a combination of ketamine hydrochloride and diazepam in dogs sedated with a combination of medetomidine and hydromorphone.
Enouri SS; Kerr CL; McDonell WN; Dyson DH
Am J Vet Res; 2008 May; 69(5):586-95. PubMed ID: 18447788
[TBL] [Abstract][Full Text] [Related]
32. The effect of naloxone on the blood level of morphine and histamine in morphine perfused dogs.
Akkan AG; Akcasu A; Yillar DO
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):594-6. PubMed ID: 3209277
[TBL] [Abstract][Full Text] [Related]
33. Detection of histamine in human placental perfusate and the effect of histamine releasers.
Kohler FW; Gautieri RF; Mann DE
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):185-200. PubMed ID: 2460906
[TBL] [Abstract][Full Text] [Related]
34. Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs.
Smith LJ; Krugner-Higby L; Trepanier LA; Flaska DE; Joers V; Heath TD
J Vet Pharmacol Ther; 2004 Oct; 27(5):369-72. PubMed ID: 15500576
[No Abstract] [Full Text] [Related]
35. Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
France CP; Jacobson AE; Woods JH
NIDA Res Monogr; 1984 Mar; 49():136-42. PubMed ID: 6207431
[No Abstract] [Full Text] [Related]
36. Elevated plasma histamine after heroin and morphine.
Brashear RE; Kelly MT; White AC
J Lab Clin Med; 1974 Mar; 83(3):451-7. PubMed ID: 4130193
[No Abstract] [Full Text] [Related]
37. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs.
KuKanich B; Schmidt BK; Krugner-Higby LA; Toerber S; Smith LJ
J Vet Pharmacol Ther; 2008 Dec; 31(6):580-3. PubMed ID: 19000282
[No Abstract] [Full Text] [Related]
39. Oxymorphone in patient-controlled analgesia.
Sinatra RS; Harrison DM
Clin Pharm; 1989 Aug; 8(8):541, 544. PubMed ID: 2475287
[No Abstract] [Full Text] [Related]
40. Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs.
Pedersoli WM; Wike JS; Ravis WR
Am J Vet Res; 1987 Apr; 48(4):679-83. PubMed ID: 3592366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
